FDA Approves OXAYDO — Zyla Life Sciences US LLC

Zyla Life Sciences US LLC has received FDA approval for OXAYDO (oxycodone hydrochloride) oral tablets, a novel formulation noted for its extended-release properties. The approval of this immediate-release tablet offers an alternative to existing analgesics and could provide Zyla with a competitive entry point in the prescription opioid market.